Table of Contents Table of Contents
Previous Page  407 / 471 Next Page
Information
Show Menu
Previous Page 407 / 471 Next Page
Page Background

© 2015 AOAC INTERNATIONAL

AOAC Official Method 2011.18

Myo-Inositol

(Free and Bound as Phosphatidylinositol)

in Infant and Pediatric Formula

and Adult Nutritionals

Liquid Chromatography/Pulsed Amperometry

with Column Switching

First Action 2011

Final Action 2014

The liquid chromatography method with electrochemical (pulsed

amperometry) detection (PAD) allows for the quantitation of myo-

inositol in infant, pediatric, and adult nutritional formulas. The

concentration of myo-inositol is calculated by comparison with

standards of known concentration. Myo-inositol, as defined by

AOAC SMPR 2011.007 (free and bound as phosphatidylinositol),

can be calculated by adding the free myo-inositol and myo-inositol

bound as phosphatidylinositol data.

The method was validated for the quantitation of free myo-

inositol and myo-inositol from phosphatidylinositol in infant,

pediatric, and adult nutritionals. Repeatability was determined

from duplicate analyses performed on multiple days. Accuracy was

determined from spike recovery experiments (free myo-inositol

and myo-inositol from phosphatidylinositol). Instrument limits

of detection and quantitation were determined statistically from

injections of low-level standards and by spiking samples with low

levels of free myo-inositol.

See

Tables

2011.18A

C

for method performance information

supporting acceptance of the method.

Caution:

Refer toMaterial SafetyData Sheets (MSDS) of chemicals

prior to use and follow safe handling procedures and the

suggested personal protective equipment. Chloroform is

a hazardous chemical and should be handled in a fume

hood. Perform the phosphatidylinositol bound myo-

inositol extraction and SPE sample cleanup procedure in

a fume hood.

A. Apparatus

(

a

)

Analytical balance

.—Minimum weighing capacity of at

least 0.0001 g.

(

b

)

Centrifuge

.

(

c

)

Desiccator

.

Table 2011.18A. Single-laboratory validation: Repeatability precision data for myo-inositol

Sample type

No. of replicates

(duplicates on multiple days)

Mean

(mg/100 g RTF)

SD

r

RSD

r

Unbound (free) myo-inositol

Infant formula (NIST SRM 1849a)

14

415

a

8.30

2.00

Infant formula powder soy-based

14

4.19

0.091

2.17

Infant formula powder milk-based

14

4.21

0.0977

2.32

Infant formula RTF milk-based

14

7.19

0.250

3.48

Infant formula powder partial hydrolyzed milk-based

14

3.38

0.0997

2.95

Infant formula powder partial hydrolyzed soy-based

14

3.10

0.0626

2.02

Infant elemental powder

14

4.85

0.148

3.06

Child formula powder

14

5.04

0.112

2.22

Infant formula RTF milk-based, unfortified

14

3.17

0.0466

1.47

Infant elemental powder, unfortified

12

1.74

0.0329

1.89

Child formula powder, spiked

12

1.94

0.0477

2.46

Adult nutritional RTF high protein, spiked

12

61.4

1.87

3.05

Myo-inositol bound as phosphatidylinositol

Infant formula (NIST SRM 1849a)

12

10.6

a

0.536

5.05

Infant formula powder soy-based

12

2.48

0.0595

2.40

Infant formula powder partial hydrolyzed milk-based

12

0.244

0.00976

4.00

Infant formula powder partial hydrolyzed soy-based

12

1.98

0.0664

3.36

Child formula powder

12

0.443

0.0196

4.43

Adult nutritional powder, milk protein-based

12

1.43

0.067

4.69

Unbound (free) myo-inositol plus myo-inositol bound as phosphatidylinositol

Infant formula (NIST SRM 1849a)

12

426a

8.35

1.96

Infant formula powder soy-based

12

6.67

0.109

1.63

Infant formula powder partial hydrolyzed milk-based

12

3.63

0.100

2.76

Infant formula powder partial hydrolyzed soy-based

12

5.08

0.0914

1.80

Child formula powder

12

5.48

0.113

2.07

a

 Results in mg/kg powder.

Candidates for 2016 Method of the Year

345